StockData
BlossomHill Therapeutics, Inc. logo

BlossomHill Therapeutics, Inc. (BLSM) stock

BLSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$15.13+1.48 (+10.84%)

Close on Nov 17, 2026Market cap $38.56MP/E –Yield –

BlossomHill Therapeutics total assets

Total assets on the balance sheet at the end of each period.

BlossomHill Therapeutics's total assets was $124.13M at Jun 30, 2026. For fiscal 2025 it was $162.97M.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$162.97M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$124.13M–
Q4 FY2025Dec 31, 2025$162.97M–

More BlossomHill Therapeutics figures

See a number that looks wrong?